Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence

Sambhawana Bhandari, Maun Ranjan Baral, Matthew Barbery, Alla Rudinskaya, Oleg Sostin

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Treatment options for various rheumatologic diseases have been limited until the introduction of biologic agents and kinase inhibitor therapy in recent decades. Since their arrival, they have steadily been integrated into routine management. Given their wide use and overall successful outcomes, it becomes increasingly pertinent for clinicians to readily identify their side effects. Their effects can involve multiple organ systems, including hematologic. This review aims to identify and classify the range of hematologic effects associated with individual biologics and kinase inhibitors used for treatment of rheumatologic diseases.

Original languageEnglish
Pages (from-to)1897-1904
Number of pages8
JournalAnnals of Hematology
Volume101
Issue number9
DOIs
StatePublished - Sep 2022

Keywords

  • Biologics
  • Co-stimulation blockers
  • Cytokine inhibitors
  • Hematologic side effects
  • Kinase inhibitors

Fingerprint

Dive into the research topics of 'Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence'. Together they form a unique fingerprint.

Cite this